Thromboprophylaxis in Lower Limb Immobilisation
Conditions: Thrombosis; Injury Leg Interventions: Drug: Rivaroxaban; Drug: Apixaban; Drug: Enoxaparin Injectable Solution; Drug: Tinzaparin Injectable Solution; Drug: Dalteparin Injectable Solution; Drug: Fondaparinux Injectable Product Sponsors: Queen Mary University of London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients
Conditions: Thrombosis; Pulmonary Embolism; Enoxaparin Interventions: Diagnostic Test: Anti-factor Xa activity calibrated for enoxaparin Sponsors: Medical University of Vienna Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy: A Multicenter, Randomized Controlled Trial.
Conditions: Radial Artery Occlusion Interventions: Drug: Subcutaneous enoxaparin sodium; Drug: Placebo Sponsors: Zhongshan Hospital (Xiamen), Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
Comparison of Apixaban Versus Enoxaparin
Conditions: Bladder Cancer Interventions: Other: apixaban; Other: enoxaparin Sponsors: Abramson Cancer Center at Penn Medicine; American Urological Association Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Conditions: Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery Interventions: Drug: SHR-2004; Drug: Enoxaparin Sodium Injection; Rivaroxaban Tablets Sponsors: Beijing Suncadia Pharmaceuticals Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
Conditions: Knee Arthroplasty, Total Interventions: Drug: Enoxaparin; Drug: KN060 Low; Drug: KN060 Middle; Drug: KN060 Hight Sponsors: Suzhou Alphamab Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
Conditions: Hepatic Disease; Surgery-Complications; Hypercoagulability; Thrombosis Interventions: Drug: Redesca (enoxaparin sodium for injection); Drug: Fragmin (dalteparin) Sponsors: Western University, Canada; Valeo Pharma Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Lovenox With Aspirin in Thawed Blastocyst Transfer
Conditions: Infertility, Female Interventions: Drug: Lovenox; Drug: Aspirin; Procedure: Embryo transfer Sponsors: Fertility Center of Las Vegas Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery
Conditions: Thromboembolism Interventions: Drug: Enoxaparin Sponsors: University of Utah Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
A Pilot Randomized Controlled Trial of Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery
Conditions: Thromboembolism Interventions: Drug: Enoxaparin Sponsors: University of Utah Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial
Conditions: Safety Issues; Effect of Drug Interventions: Drug: Enoxaparin sodium injection Sponsors: PT Bio Farma Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy
Conditions: Blood Loss; Intensive Care; Anastomotic Leakage; Lymph Node Disease; Survival; Blood Transfusion Interventions: Procedure: LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention); Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution; Drug: Levofloxacin 500mg; Procedure: LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (Conventional) Sponsors: General Committee of Teaching Hospitals and Institutes, Egypt Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma
Condition: Thromboembolism, Venous Intervention: Drug: enoxaparin Sponsor: Methodist Health System Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials
